Open Label Study of TRx0014 in Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

September 13, 2007

Primary Completion Date

December 2, 2010

Study Completion Date

December 2, 2010

Conditions
Alzheimer's Disease
Interventions
DRUG

TRx0014

Gelatin capsule, tid

All Listed Sponsors
lead

TauRx Therapeutics Ltd

INDUSTRY

NCT00684944 - Open Label Study of TRx0014 in Alzheimer's Disease | Biotech Hunter | Biotech Hunter